Tessenderlo Group has completed a minority equity investment in FMC Corporation, purchasing approximately 30.3 million shares at $13.30 per share for around $403 million. The Belgian industrial group now owns roughly 20% of the US agricultural sciences company's outstanding common stock. The transaction, first announced on 30 June 2026, received all necessary regulatory approvals. As part of the deal, Tessenderlo Group has the right to nominate one independent director to FMC's board and has put forward its chief executive officer, Luc Tack. Tessenderlo Group is subject to customary standstill restrictions and a three-year lock-up period on its shares. FMC develops crop protection solutions including biologicals and precision agriculture technologies. Tessenderlo Group, which operates in over 100 countries, recorded consolidated revenue of €2.8 billion in 2025.

FMC Corporation reported second quarter 2026 revenue of $867 million, down 17% year-over-year, with adjusted EBITDA of $153 million exceeding guidance. Excluding India, revenue fell 20% to $841 million, with organic revenue declining 22%. The company posted a GAAP net loss of $187 million, or $1.49 per diluted share. Adjusted earnings per share reached $0.26, down 62% from the prior year. Cash from operations rose significantly to $363 million, up $297 million year-over-year. FMC lowered its full-year outlook due to challenging macroeconomic conditions. The company now expects revenue excluding India of $3.50 billion to $3.70 billion and adjusted EBITDA between $620 million and $680 million. Free cash flow guidance increased to $75 million to $225 million, including a $200 million upfront licensing payment for rimisoxafen.

Tessenderlo Group has agreed to invest $400 million in FMC Corporation for a 20% stake at $13.30 per share, valuing the agricultural sciences company at approximately $2 billion. The transaction concludes FMC's strategic review initiated in February 2026 and supports its $1 billion debt reduction target. The Belgian industrial group described the investment as part of its strategy to acquire cornerstone minority stakes in high-quality agricultural companies. FMC said the agreement aligns with its operational plans, including advancing its R&D pipeline and commercialising new innovations. The deal follows recent FMC initiatives including a $1.2 billion bond offering, the $252 million sale of its India business, and a $200 million prepayment from Corteva. The transaction requires regulatory approvals and customary closing conditions.